tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Recommendation for Lexaria Bioscience Based on Improved Safety Profile of DehydraTECH-semaglutide
PremiumRatingsBuy Recommendation for Lexaria Bioscience Based on Improved Safety Profile of DehydraTECH-semaglutide
1M ago
Lexaria Bioscience price target lowered to $4 from $5 at H.C. Wainwright
Premium
The Fly
Lexaria Bioscience price target lowered to $4 from $5 at H.C. Wainwright
1M ago
Lexaria Bioscience Reports Promising Interim Results in GLP-1 Study
Premium
Company Announcements
Lexaria Bioscience Reports Promising Interim Results in GLP-1 Study
1M ago
Lexaria Bioscience Achieves 50 Patents Milestone with New International Grants
PremiumCompany AnnouncementsLexaria Bioscience Achieves 50 Patents Milestone with New International Grants
3M ago
Lexaria Bioscience receives two international patents
Premium
The Fly
Lexaria Bioscience receives two international patents
3M ago
Lexaria’s Oral Liraglutide Shows Promise in Reducing Adverse Events
Premium
Company Announcements
Lexaria’s Oral Liraglutide Shows Promise in Reducing Adverse Events
3M ago
Lexaria Bioscience Secures $2 Million in Direct Stock Offering
PremiumCompany AnnouncementsLexaria Bioscience Secures $2 Million in Direct Stock Offering
4M ago
Lexaria Bioscience Secures $2 Million in Direct Stock Offering
Premium
Company Announcements
Lexaria Bioscience Secures $2 Million in Direct Stock Offering
5M ago
Lexaria Bioscience prices 2M shares at $1.00 in registered direct offering
Premium
The Fly
Lexaria Bioscience prices 2M shares at $1.00 in registered direct offering
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100